I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inno-Gene SA
Cost of Revenue Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Cost of Revenue
-zł666k
CAGR 3-Years
51%
CAGR 5-Years
-6%
CAGR 10-Years
13%
M
Medicofarma Biotech SA
WSE:MDB
Cost of Revenue
-zł259.4k
CAGR 3-Years
55%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Cost of Revenue
-zł21.3m
CAGR 3-Years
-28%
CAGR 5-Years
20%
CAGR 10-Years
-6%
S
Selvita SA
WSE:SLV
Cost of Revenue
-zł70.1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Cost of Revenue?
Cost of Revenue
-666k PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Cost of Revenue amounts to -666k PLN.

What is Inno-Gene SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
13%

Over the last year, the Cost of Revenue growth was 94%. The average annual Cost of Revenue growth rates for Inno-Gene SA have been 51% over the past three years , -6% over the past five years , and 13% over the past ten years .

Back to Top